<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article216</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/Transfusion_Strategies_for_Acute_Upper_Gastrointestinal_Bleeding" style="display:block; margin-bottom:10px;">Transfusion Strategies for Acute Upper Gastrointestinal Bleeding Original</a></li>
<h2><strong>Transfusion Strategies for Acute Upper Gastrointestinal Bleeding</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Restrictive versus Liberal Transfusion Strategy in Patients with Acute Upper Gastrointestinal Bleeding".The New England Journal of Medicine. 2013. 368:11-21.PubMed•ClinicalTrials.gov number, NCT00414713•PDF<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In patients with acute upper gastrointestinal bleeding, is a restrictive transfusion strategy (transfusion at Hb &lt;7 g/dL) more effective and safer than a liberal transfusion strategy (transfusion at Hb &lt;9 g/dL)?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Among patients with acute upper gastrointestinal bleeding, a restrictive transfusion strategy (Hb threshold for transfusion, &lt;7 g/dL) improved survival rates and other clinical outcomes compared with a liberal transfusion strategy (Hb threshold for transfusion, &lt;9 g/dL).<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
A restrictive transfusion strategy (transfusing when Hb &lt;7 g/dL) led to higher survival rates at 6 weeks (95% vs. 91%) and decreased rates of repeat bleeding and adverse events compared with a liberal transfusion strategy (transfusing when Hb &lt;9 g/dL) in patients with upper gastrointestinal bleeding.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Following the results of this trial, international guidelines suggest lowering the Hb threshold for transfusion in patients with gastrointestinal bleeding from 10 g/dL to 7 g/dL.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized, controlled trial<br/>
- N=921 patients with acute upper gastrointestinal bleeding<br/>
- Restrictive strategy (n=461), liberal strategy (n=460)<br/>
- Setting: Single center in Barcelona, Spain<br/>
- Enrollment: 2003-2009<br/>
- Follow up: 45 days<br/>
- Analysis: Intention-to-treat<br/>
- Primary outcome: All-cause mortality at 45 days<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria:<br/>
- Patients ≥18 years old with hematemesis, melena, or both<br/>
- Hospital staff confirmation of bleeding<br/>
<br/>
Exclusion Criteria:<br/>
- Refusal of blood transfusion<br/>
- Massive exsanguinating bleeding, recent acute coronary syndrome, symptomatic peripheral vasculopathy, stroke, recent trauma or surgery, lower GI bleeding, recent transfusion, clinical Rockall score of 0 with Hb &gt;12 g/dL<br/>
<br/>
Baseline Characteristics<br/>
- Similar between groups<br/>
- 31% had cirrhosis<br/>
- Bleeding source: peptic ulcer (49%), esophageal varices (21%)<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Restrictive strategy: Transfuse if Hb &lt;7 g/dL<br/>
- Liberal strategy: Transfuse if Hb &lt;9 g/dL<br/>
- Followed until discharge or death<br/>
- Protocol deviations allowed for clinically significant anemia, massive rebleeding, or need for surgical intervention<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcomes<br/>
- 45-day all-cause mortality: Restrictive group 5% vs. Liberal group 9% (P=0.02)<br/>
<br/>
Secondary Outcomes<br/>
- Further bleeding: Restrictive group 10% vs. Liberal group 16% (P=0.01)<br/>
- In-hospital complications: Restrictive group 40% vs. Liberal group 48% (P=0.02)<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Not generalizable to all patients with gastrointestinal bleeding, such as those with low-risk or massive exsanguinating hemorrhage<br/>
- Potential bias due to non-blinded design<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
- Fundació Investigació Sant Pau<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
Updates to the article and related letters can be found at NEJM.org.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
